RELMADA THERAPEUTICS, INC. (RLMD) Operating cash flow 2016–2025
RELMADA THERAPEUTICS, INC. (RLMD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$45.8MFY2025 · since FY2016: -$6.5M → -$45.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$45.8M | +11.5% |
| FY2024 | -$51.8M | -0.2% |
| FY2023 | -$51.7M | +50.2% |
| FY2022 | -$103.8M | -13.0% |
| FY2021 | -$91.9M | -230.4% |
| FY2020 | -$27.8M | -130.0% |
| FY2019 | -$12.1M | -15.2% |
| FY2018 | -$10.5M | -74.9% |
| FY2017 | -$6.0M | +7.2% |
| FY2016 | -$6.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RLMD financial trends
RLMD RevenueRLMD Net incomeRLMD Net marginRLMD Gross profitRLMD Gross marginRLMD Operating incomeRLMD Operating marginRLMD Free cash flowRLMD Capital expendituresRLMD Return on equityRLMD Stock buybacksRLMD Dividends paidRLMD Total assetsRLMD Total liabilitiesRLMD Shareholders’ equityRLMD overview →